{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=84", "query": { "intervention": "Protein Control", "page": 84 }, "page_size": 10 }, "pagination": { "page": 84, "page_size": 10, "total_count": 3500, "total_pages": 350, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=85&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=83&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-07T19:26:55.804Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03423823", "title": "Ziv-aflibercept Efficacy in Better Regulating AMD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Wet Macular Degeneration", "Wet Age-related Macular Degeneration" ], "interventions": [ { "name": "Ziv-Aflibercept 25 MG/ML [Zaltrap]", "type": "DRUG" }, { "name": "Ranibizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kapil Kapoor", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "50 Years to 99 Years" }, "enrollment_count": 62, "start_date": "2017-07-07", "completion_date": "2020-06-26", "has_results": false, "last_update_posted_date": "2020-10-06", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 1, "location_summary": "Virginia Beach, Virginia", "locations": [ { "city": "Virginia Beach", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03423823" }, { "nct_id": "NCT03496662", "title": "BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Ductal Adenocarcinoma" ], "interventions": [ { "name": "BMS-813160", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Nab-paclitaxel", "type": "DRUG" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Peripheral blood", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2018-08-31", "completion_date": "2024-07-25", "has_results": true, "last_update_posted_date": "2025-07-29", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03496662" }, { "nct_id": "NCT06565546", "title": "CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ventral Hernia" ], "interventions": [ { "name": "Opioid pain medication prescribed based on CYP2D6 genotype testing PLUS Acetaminophen and Gabapentin", "type": "OTHER" }, { "name": "Acetaminophen and Gabapentin: standard postoperative pain medications", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 100, "start_date": "2025-01-29", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06565546" }, { "nct_id": "NCT02072096", "title": "A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Glimepiride", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Linagliptin", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Insulin Glargine", "type": "DRUG" }, { "name": "Exenatide once weekly (QW)", "type": "DRUG" }, { "name": "Exenatide twice daily (BID)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 192, "start_date": "2014-02", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2019-10-09", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 16, "location_summary": "Miami, Florida • New Port Richey, Florida • Orlando, Florida + 12 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "New Port Richey", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Athens", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02072096" }, { "nct_id": "NCT01077362", "title": "A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "ustekinumab 45 mg", "type": "DRUG" }, { "name": "ustekinumab 90 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 312, "start_date": "2010-03", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2014-02-27", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Los Angeles, California + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01077362" }, { "nct_id": "NCT01786707", "title": "Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Autologous stem cells", "type": "BIOLOGICAL" }, { "name": "Hyperbaric oxygen therapy", "type": "OTHER" }, { "name": "Insulin", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "OTHER", "DRUG" ], "sponsor": "Rodolfo Alejandro", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "45 Years to 65 Years" }, "enrollment_count": 2, "start_date": "2009-07", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01786707" }, { "nct_id": "NCT00005095", "title": "Specimen and Data Study for Ovarian Cancer Early Detection and Prevention", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Cancer", "Endometrial Cancer", "Fallopian Tube Cancer", "Hereditary Breast/Ovarian Cancer (brca1, brca2)", "Ovarian Cancer", "Sarcoma", "Uterine Leiomyomata", "Vaginal Cancer", "Vulvar Cancer" ], "interventions": [ { "name": "Ca-125", "type": "OTHER" }, { "name": "screening questionnaire administration", "type": "OTHER" }, { "name": "Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "FEMALE", "summary": "18 Years to 80 Years · Female only" }, "enrollment_count": 6000, "start_date": "2000-03", "completion_date": "2040-12", "has_results": false, "last_update_posted_date": "2025-02-28", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005095" }, { "nct_id": "NCT06673667", "title": "First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants Study" ], "interventions": [ { "name": "KT-621", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kymera Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "19 Years to 55 Years" }, "enrollment_count": 118, "start_date": "2024-10-22", "completion_date": "2025-04-23", "has_results": false, "last_update_posted_date": "2025-10-02", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 2, "location_summary": "Phoenix, Arizona • Lincoln, Nebraska", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06673667" }, { "nct_id": "NCT03115775", "title": "CLA and Vitamin D on Protein Turnover", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Protein" ], "interventions": [ { "name": "Conjugated linoleic acid", "type": "DIETARY_SUPPLEMENT" }, { "name": "Vitamin D", "type": "DIETARY_SUPPLEMENT" }, { "name": "Conjugated linoleic acid and Vitamin D", "type": "DIETARY_SUPPLEMENT" }, { "name": "Corn oil (placebo)", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "65 Years to 85 Years" }, "enrollment_count": 40, "start_date": "2017-05-12", "completion_date": "2019-08-31", "has_results": false, "last_update_posted_date": "2019-11-21", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03115775" }, { "nct_id": "NCT07211412", "title": "Acute Cryotherapy on Musculoskeletal Function and Biomarkers", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Exercise Induced Muscle Damage", "Cryotherapy" ], "interventions": [ { "name": "Cryotherapy", "type": "OTHER" }, { "name": "Eccentric exercise-induced muscle damage", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Texas, El Paso", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 60, "start_date": "2025-11-15", "completion_date": "2028-05-15", "has_results": false, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-11-07T19:26:55.804Z", "location_count": 1, "location_summary": "El Paso, Texas", "locations": [ { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07211412" } ] }